Revolution Beauty confirms Frasers Group interest in sale process

Revolution Beauty Group Plc (LON:REVB) has noted the recent press speculation regarding the interest of Frasers Group plc in Revolution Beauty and confirms that Frasers is one of a number of parties conducting due diligence as part of the Formal Sale Process announced on 21 May 2025. There can be no certainty that Frasers’ interest will result in a firm offer for the Company.

Further updates will be provided if and when appropriate. Shareholders are advised to take no action at this time.

Share on:

Written by: Amilia Stone

Latest Company News

Ilika plc: ORKA Launch Opens New Commercial Opportunities for Goliath in Marine and Defence Markets (video)

October 23, 2026

Ilika CEO Graeme Purdy explains how ORKA could accelerate Goliath's commercialisation through underwater defence applications while maintaining the company's long-term electric vehicle strategy.

Unite Group sells Hawthorne House academy school for £40.7 million

October 23, 2026

Unite Group has exchanged contracts to sell the academy school at its Hawthorne House development in London for £40.7 million. The sale forms part of its asset disposal strategy, with proceeds initially earmarked for debt reduction.

Rio Tinto to invest $1.9 billion in Queensland bauxite project

October 23, 2026

Rio Tinto will invest US$1.9 billion to develop the Kangwinan bauxite project in Queensland, increasing Weipa Operations’ annual capacity to around 44 million tonnes. First production is targeted for 2029, with construction expected to support more than 1,300 jobs.

Edinburgh Investment Trust raises interim dividend by 10.5%

October 23, 2026

Edinburgh Investment Trust has declared a first interim dividend of 8.40 pence per ordinary share for the year ending 31 March 2027, up from 7.60 pence in 2026. The dividend is payable on 20 November 2026 to shareholders on the register on 6 November.

Cizzle Biotechnology to present CIZ1B lung cancer test advances at SYNLAB Symposium

October 23, 2026

Cizzle Biotechnology will present improvements to its CIZ1B lung cancer biomarker test at the SYNLAB Innovation Academy Symposium on 5 November 2026, highlighting technical evaluation work with the Christie Pathology Partnership and peer-reviewed research demonstrating test accuracy and reproducibility.

Arbuthnot Banking Group lifts 2026 profit outlook after double-digit growth in lending, deposits and wealth assets

October 22, 2026

Arbuthnot Banking Group said stronger lending, wealth management momentum and stable rates mean 2026 profit before tax should beat earlier expectations.

Revolution Beauty confirms Frasers Group interest in sale process

Latest Company News

Search

Follow us on Social Media: